英文品名 |
etaracizumab |
名称来源 |
p-INNList-99,2008;r-INNList-61,2009; |
化学表述 |
immunoglobulin G1, anti-[Homo sapiens alphaVbeta3 integrin(CD51/CD61, CD51/GPIIIa, CD51/platelet membrane glycoproteinIIIa, vitronectin receptor)], humanized monoclonal antibody, MEDI-522 (or hLM609); gamma1 heavy chain (1-447) [humanized VH(Homo sapiens FR/Mus musculus CDR from clone LM609-Homosapiens IGHJ5*01, L123>T) [8.8.10] (1-117) -Homo sapiensIGHG1*03 (118-447)], (220-214’)-disulfide with kappa light chain(1'-214') [humanized V-KAPPA (Homo sapiens FR/Mus musculusCDR from clone LM609-Homo sapiens IGKJ4*01) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')]; (226-226”:230-230”)-bisdisulfide dimer |
CA登记号 |
892553-42-3 |
分 子 式 |
C6392H9908N1732O1996S42 |
结 构 式 |
|
品种类别 |
antineoplastic; |
|